In This Issue of Condé Nast Portfolio

Home > Resources > Company Profiles > deCODE Genetics Inc.

deCODE Genetics Inc. (DCGN)

Your Name

Your Email Address *
Send a copy to me

Recipient's Email Address *

Separate multiple email addresses (max 20) with commas.

Subject *

Message

0/1500

Enter the text you see in the image *

Letters are not case-sensitive, disregard spaces.

Try a New One

This helps us prevent automated registrations and spamming.

Email Confirmation

Dr. Kari Stefansson, M.D. , Founder/CEO/Chairman of the Board/President/Director

www.decode.com

Industry: Professional Services

OPEN

LAST

PREV CLOSE

CHANGE

VOLUME

Overview

News

People

Financials

Overview

A biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases.

Press Releases

BeaconEquity.com Issues Technical Trade Alerts on Market Movers: LVLT, ISRG, JBLU, SBUX, TSFG, DCGN Jul-23-2008, 09:20AM EDT
Zacks Analyst Blog Highlights: deCODE genetics, Monogram, United States Cellular, Telephone and Data Systems and Canon Jul-02-2008, 06:00AM EDT
Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event Jun-30-2008, 09:40AM EDT
deCODE genetics to Webcast Presentations at Annual R&D Event Jun-30-2008, 08:25AM EDT
DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin Jun-30-2008, 08:19AM EDT

News From Around the Web

News

Discovering Genes That Cause Disease (NBC 6 Pocatello (KPVI))

Jul 22 2008
You 2.0: Comparison Shopping for Your Future (Entrepreneur)

Apr 23 2008

Employees

Number of Employees: 431

Revenue per Employee: $89,769

Top Executives

Dr. Daniel Hartman, M.D., Divisional Senior VP

Lance Thibault, CPA, CFO/Treasurer

Dr. Mark Gurney, Ph.D, Divisional Senior VP

Jakob Sigurdsson, Senior VP, Divisional

Axel Nielsen, COO

Board of Directors

James Beery, Director

Lance Thibault, CPA, CFO/Treasurer

J. Neal Armstrong, Director

Earl M. Collier, Jr., Director

Dr. Linda B. Buck, Ph.D., Director

Dr. Peter Goodfellow, Director

Terrance G. McGuire, Vice Chairman/Director

Birgit Stattin Norinder, Director

Financials

Quarterly

Annual

Income Statement	05/2008	03/2008	12/2007	08/2007
Sales	11.73 Mil.	12.54 Mil.	9.64 Mil.	6.83 Mil.
Gross Operating Profit	3.25 Mil.	799 K.	1.25 Mil.	786 K.
Operating Income before D & A (EBITDA)	-16.61 Mil.	-19.5 Mil.	-19.88 Mil.	-20.54 Mil.
Total Income Before Interest Expenses (EBIT)	-22.64 Mil.	-28.27 Mil.	-20.23 Mil.	-12.42 Mil.
Total Net Income	-26.66 Mil.	-32.42 Mil.	-24.25 Mil.	-16.23 Mil.
Basic EPS, Total	-0.44	-0.54	-0.4	-0.27
Diluted EPS, Total	-0.44	-0.54	-0.4	-0.27

BALANCE STATEMENT	05/2008	03/2008	12/2007	08/2007
Cash and Equivalents	42.73 Mil.	54.17 Mil.	45.84 Mil.	43.76 Mil.
Total Assets	65.19 Mil.	82.65 Mil.	137.08 Mil.	153.32 Mil.
Total Liabilities	36.14 Mil.	34.26 Mil.	32.44 Mil.	27.32 Mil.
Total Capitalization	66.92 Mil.	65.61 Mil.	120.2 Mil.	142.24 Mil.

Cash Flow	05/2008	03/2008	12/2007	08/2007
Net Cash From Continuing Operations	-20.03 Mil.	-63.89 Mil.	-49.61 Mil.	-30.95 Mil.
Net Cash From Investing Activities	9.29 Mil.	78.53 Mil.	55.02 Mil.	35.72 Mil.
Net Cash From Financing Activities	-704 K.	17.65 Mil.	18.55 Mil.	17.11 Mil.
Net Change in Cash & Cash Equivalents	-11.44 Mil.	32.29 Mil.	23.96 Mil.	21.88 Mil.

Income Statement	2008	2007	2006	2005
Sales	37.01 Mil.	36.03 Mil.	30.1 Mil.	28.4 Mil.
Gross Operating Profit	3.39 Mil.	4.48 Mil.	13.86 Mil.	13.73 Mil.
Operating Income before D & A (EBITDA)	-77.57 Mil.	-77.84 Mil.	-50.01 Mil.	-31.4 Mil.
Total Income Before Interest Expenses (EBIT)	-79.88 Mil.	-77.66 Mil.	-55.27 Mil.	-48.27 Mil.
Total Net Income	-95.53 Mil.	-85.47 Mil.	-62.75 Mil.	-57.26 Mil.
Basic EPS, Total	-1.57	-1.49	-1.17	-1.07
Diluted EPS, Total	-1.57	-1.49	-1.17	-1.07

BALANCE STATEMENT	2008	2007	2006	2005
Cash and Equivalents	54.17 Mil.	21.88 Mil.	65.94 Mil.	70.24 Mil.
Total Assets	82.65 Mil.	169.71 Mil.	166.95 Mil.	203.08 Mil.
Total Liabilities	34.26 Mil.	23.5 Mil.	25.52 Mil.	37.91 Mil.
Total Capitalization	65.61 Mil.	156.68 Mil.	146.32 Mil.	241.93 Mil.

Cash Flow	2008	2007	2006	2005
Net Cash From Continuing Operations	-63.89 Mil.	-85.17 Mil.	-54.03 Mil.	-29.94 Mil.
Net Cash From Investing Activities	78.53 Mil.	-44.42 Mil.	95.83 Mil.	-124.65 Mil.
Net Cash From Financing Activities	17.65 Mil.	85.53 Mil.	-46.09 Mil.	156.16 Mil.
Net Change in Cash & Cash Equivalents	32.29 Mil.	-44.06 Mil.	-4.3 Mil.	1.57 Mil.

Subscription Services Think Tank Topics

RSS

Mobile

visit our sister sites

Subscribe and get a FREE gift!

visit our partner sites

AOL Money & Finance

Bizjournals.com

Dealbreaker

Entrepreneur.com

Harvard Business

Yahoo! Finance

Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions. Company fundamental data provided by Hemscott. Economic data provided by Econoday. News provided by Comtex. Sec Filings data provided by Edgars. The Wall Street Horizon National Consumer Interest Rate Survey. ©2008 Wall Street Horizon. PMMS Mortgage Data ©2008 Freddie Mac. Mortgage averages are for conforming mortgages with 20% down.

deCODE Genetics Inc. (DCGN)

Company Information

Overview

Employees

Top Executives

Board of Directors

Financials

Company Profile Change Request